Micro Pharmaceuticals
Market Cap
₹936 Cr.
P/E
40.19

Key Ratios

Market cap
Market cap
936 Cr
PE
PE
40.19
Prom Holding
Prom Holding
57.39 %
ROE (%)
ROE (%)
12.14
ROCE (%)
ROCE (%)
28.18
Div Yield (%)
Div Yield (%)
-
Sales
Sales
703 Cr
OPM (%)
OPM (%)
7.30 %
Debt to Equity
Debt to Equity
1.34
Institutions
Institutions
20.00 %
Individual < 2 lac
Individual < 2 lac
7.42 %
No. of Shareholders
No. of Shareholders
1,346

About

Sudarshan Pharma Industries Limited is engaged in contract manufacturing, outsource &amp; Supp… Read more
Low
19
52W Range
High
40
  • Sudarshan Pharma (I)
  • Bharat Parenterals
  • Wanbury

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Sudarshan Pharma Industries Ltd. Business

Sudarshan Pharma Industries Limited is a company engaged in contract manufacturing and supplying generic pharmaceutical formulations and medicines to healthcare institutions, governments, NGOs, and hospitals through outsourcing and import-export services.

Sudarshan Pharma (I) major competitors are Bharat Parenterals, Wanbury, Kopran, Themis Medicare, Anlon Healthcare, Fermenta Biotech, Shree Ganesh Remed..
Market Cap of Sudarshan Pharma (I) is ₹965 Crs.
While the median market cap of its peers are ₹960 Crs.

Sudarshan Pharma (I) seems to be less financially stable compared to its competitors.
Altman Z score of Sudarshan Pharma (I) is 2.8 and is ranked 8 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Jan May May Aug Jul Dec Jan Mar Sep
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material